GlaxoSmithKline Proprietary Ltd.

Star Scientific Plans Worldwide Marketing and Sales of CigRx™ Nutraceutical in Partnership with inVentiv Health.
Cancer Weekly; 11/17/2009; 958 words; ...cancer detection through proprietary autoantibody assay...industry leaders such as GlaxoSmithKline, Orthobiotech and...Officer of Oncimmune, LTD. Ongoing research...subsidiary of Oncimmune LTD. Oncimmune LTD owns...Detection, Diagnostics, GlaxoSmithKline, Lung Cancer, Lung...

www.Xtremepicks.Com: Xtremepicks Alerts November 16, 2009 : NABI, AVGO, ECLP and MLNX.
M2 Presswire; 11/16/2009; 1812 words; ...and Mellanox(R) Technologies, Ltd. (NASDAQ: MLNX) (TASE:MLNX...conjugate candidate vaccine, between GlaxoSmithKline Biologicals SA and Nabi Biopharmaceuticals...Conjugate Vaccine), an innovative and proprietary investigational vaccine for treatment...

Other News To Note.
BIOWORLD Today; 11/3/2009; 1416 words; ...Nasdaq rules. o EvoGenix Ltd., of Sydney, Australia...EvoGenix will apply its proprietary technologies to advance...option agreement with GlaxoSmithKline plc, of London. The...Y., and Sosei Co. Ltd., of Tokyo, are collaborating...platform and PsychoGenics' proprietary drug discovery ...

Clinic Roundup.
BIOWORLD Today; 11/3/2009; 1426 words; ...o Meditor Pharmaceuticals Ltd., of Rehovot, Israel, said...o Metabolic Pharmaceuticals Ltd., of Melbourne, Australia...ingredient in London-based GlaxoSmithKline plc's leading migraine remedy...Camptothecin. Formulated with its proprietary vitamin E-based technology...

Advaxis Chief Science Officer to Present Benefits of Using Live Listeria as a Vaccine.
Business Wire; 10/15/2009; 1103 words; ...executives from F. Hoffmann-La Roche Ltd., (OTCQX: RHHBY.PK), Johnson...JNJ), Allergan (NYSE: AGN), and GlaxoSmithKline (LSE: GSK | NYSE: GSK). Dr. Rothman...New Jersey, Advaxis is developing proprietary Listeria monocytogenes (Lm) cancer...